Oxidative Stress Gene Signature Flags Prostate Cancer Recurrence Risk
A LASSO-based risk score built from oxidative stress-related genes predicts biochemical recurrence in prostate cancer, with LAMP5 knockdown reducing PC3 ...
A LASSO-based risk score built from oxidative stress-related genes predicts biochemical recurrence in prostate cancer, with LAMP5 knockdown reducing PC3 ...
A four-gene transcriptomic signature stratifies prostate cancer patients by biochemical recurrence risk and identifies SPAG5 as a targetable oncogene.
Researchers validated HPLC and TLC analytical methods for measuring the radiochemical purity of the zirconium-89 labelled PSMA-I&T radiotracer ahead of ...
A prospective study of 24 men found that 18F-Flotufolastat PSMA PET MRI detected recurrent prostate cancer in 25 percent of ...
An integrated sequencing analysis identified MKI67, MIPEP and CCNA2 as candidate prognostic biomarkers for biochemical recurrence risk in prostate cancer.
A retrospective study of 200 patients found that shortened 68Ga-PSMA PET/CT protocols miss tumor manifestations in a minority of patients ...
The multicenter StereoBed trial will randomize 284 patients to compare five-fraction stereotactic radiotherapy with standard schedules after prostatectomy, with two-year ...
A TCGA-based prostate cancer study developed a coagulation-associated lncRNA prognostic signature, found distinct immune-related features in high-risk patients, and showed ...
A BMC Cancer abstract reports that public-dataset modeling identified a four-gene prognostic model for prostate adenocarcinoma biochemical recurrence, with supporting ...
A bi-institutional study of 179 patients shows PSMA PET/CT-guided salvage elective nodal radiotherapy combined with hormone therapy delivers durable five-year ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine